April 17, 2014

April 17, 2018

March 17, 2015

Attendees at Fakuma 2023 are encouraged to visit Avient’s booth 5316 in Hall B5 from October 17 – 21 in Friedrichshafen, Germany to learn more.  

PolyOne will have representatives on hand next week to discuss this technology at Luxe Pack New York, May 16 - 17, in stand D302.

The final composite assembly is 17% lighter than the aluminum structure, while also upping the game on flexural stiffness and torsional rigidity.

name change effective from 17/05/2021) :Company Name 201916958NUEN : This is to confirm that the company was incorporated under the Companies Act, on and from 27/05/2019 and that the company is a PRIVATE COMPANY LIMITED BY SHARES. The company was formerly known as: S/N Company Name Effective From 1. Any change in company name effected before 13 Jan 2003 will not be listed) TAN YONG TAT ACCOUNTING AND CORPORATE REGULATORY AUTHORITY : 17/05/2021 : Dated SINGAPORE ACRA210517158352Receipt Number ASST REGISTRAR OF COMPANIES & BUSINESS NAMES Authentication No. : A21361131U

I N V E S T M E N T I N C O M M E RC I A L R E S O U RC E S D R I V E S I N N O V AT I V E P R O D U C T P O R T F O L I O A N D S A L E S G R O W T H 19 160 270 2011 2019 2020E 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 11 12 13 14 15 16 17 18 19 20 21E 2.5x TARGET NET LEVERAGE BY 2021 ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$350MM PAID OVER LAST 10 YEARS R E T U R N I N G VA LU E TO S H A R E H O L D E R S 12 Free Cash Flow Dividends Share Repurchases Deleveraging Strong track record of cash generation put to work in M&A and return to shareholders while modestly levered 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 11 12 13 14 15 16 17 18 19 20 2.9x 2.5x 2020PF* 2021E Growing Dividend Cumulative Buybacks Net Leverage $ B n $ p e r s h a re *2020 estimate and Pro forma for acquisition of the Clariant Masterbatch business Cash Generation ~$270MM Another unique value creation lever at Avient is synergy capture with our recent acquisition of Clariant Masterbatch. Excluding our Distribution segment and pro forma with synergies, EBITDA margins at Avient will exceed 17%. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 17 Capex / Revenue 2021E (%) Source: Bloomberg market data as of November 9, 2020 AV I E N T I S A S S E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 3 6 3 4 5 5 5 5 5 6 6 7 7 9 24 A v ie n t A v ie n t (E x c l.

Microsoft PowerPoint - Avient February IR Meetings AVIENT CORPORATION (NYSE: AVNT) F E B R U A R Y 1 7 - 1 8 , 2 0 2 1 I N V E S T O R M E E T I N G S H O S T E D B Y G O L D M A N S A C H S A N D M O R G A N S T A N L E Y D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. W H AT W E D O : M AT E R I A L S C I E N C E 5 CUSTOM FORMULATION We sell solutions not commodities. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 27 Avient reflects 2021 estimated EBITDA of $510M O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 21.1 13.2 13.2 12.0 12.0 9.7 25.2 23.1 14.7 13.5 12.9 11.0 11.0 11.0 10.2 9.6 9.3 9.3 9.1 8.6 8.3 A vi e n t K W R A V Y R P M G C P P P G F U L A L B E C L H X L IF F F M C G R A B N R F O E A S H C E S C L U N V R E M N H U N K R A Median: 11.0xMedian: 12.6x S U M M A RY: W H Y I N V E S T I N AV I E N T ?

Microsoft PowerPoint - AVNT Q4 2021 Earnings Presentation (v17) - W PEERS x ESI AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 1 R E S U L T S A N D 2 0 2 2 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 8 , 2 0 2 2 D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. O U R VA LUATI O N V E R S U S P E E R S Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 6 ) A vi e n t (2 0 2 1 ) A vi e n t (T o d a y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple S U M M A RY: W H Y I N V E S T I N AV I E N T ?